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Background
By comparative analysis of the bacterial genomesm of
Streptococcus suis serotype 2 both virulent and avirulent
strains are instrumental in the development of vaccines
and the functional characterization of important of
genetic determinants.
Methods
We isolated from a clinically healthy pig an avirulent
strain, 05HAS68.
Results
By comparing the genomes of the virulent and avirulent
strains, we observed massive genome rearrangements
that may result in alterations in gene expression and, in
turn, causing enormous single gene gain and loss for the
S. suis 2 species. It is most interesting that both virulent
and avirulent species feature a similarly structured geno-
mic island (GEI) which carries different idiosyncratic
systems as an adoptive evolutionary response. Strikingly,
all of the animals vaccinated with the avirulent strain
05HAS68 were protected from challenge infection with
the most virulent S. suis 2 strain, 05ZYH33, and,
furthermore, the protective immunity could be trans-
ferred with T cells and plasma from the vaccinated pigs
to unimmunized animals. Increased production of
tumor necrosis factor alpha (TNF-alpha) and gamma
interferon (IFN-gamma) in peripheral blood of the
immunized animals may be attributed to the protective
immunity elicited by the live vaccine.
Discussion
Since the S. suis 2 strains command large genetic diver-
sity, it is almost impossible to achieve global protection
for all S. suis 2 pathogenic strains by depending on one,
or even several, virulence-related substances as vaccines.
In view of our results, both humoral and cellular immu-
nities induced by live 05HAS68-based vaccine are
required for the specific protection against virulent
S. suis strains; therefore, we suggest reconsideration of
research strategy in terms of model strains to test for
vaccine design.
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